Comparing Neurofilament Light Chain Levels in Serum and Plasma

참고문헌 (9)

1. Khalil M, "Neurofilaments as biomarkers in neurological disorders", Nat Rev Neurol, 14, pp.577~589 (2018)
2. 박선아, "Promising Blood Biomarkers for Clinical Use in Alzheimer’s Disease: A Focused Update", Journal of Clinical Neurology, 18(4), pp.401~409 (2022), 대한신경과학회
3. Forgrave LM, "The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer’s disease, frontotemporal dementia, and amyotrophic lateral sclerosis : a systematic review and meta-analysis", Alzheimers Dement(Amst), 11, pp.730~743 (2019)
4. Mattsson N, "Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease", JAMA Neurol, 74, pp.557~566 (2017)
5. Lee EH, "Serum neurofilament light chain level as a predictor of cognitive stage transition", Alzheimers Res Ther, 14, pp.6~ (2022)
6. Altmann P, "Seven day pre-analytical stability of serum and plasma neurofilament light chain", Sci Rep, 11, pp.11034~ (2021)
7. Hviid CV, "Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults", Scand J Clin Lab Invest, 80, pp.291~295 (2020)
8. Florbetaben : a review in β-amyloid PET imaging in cognitive impairment, "CNS Drugs", 2015, 605~613
9. Harp CT, "Neurofilament light chain(NfL)levels in CSF, serum, and plasma of healthy donors using the Quanterix NfL Advantage Kit™(P1. 9-032)", Neurology, 92, pp.P1.9~P1.032 (2019)[DOI]

관련 논문AI추천